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Abstract
Background: Reelin is a large secreted protein of the extracellular matrix that has been proposed to participate to the
etiology of schizophrenia. During development, reelin is crucial for the correct cytoarchitecture of laminated brain structures
and is produced by a subset of neurons named Cajal-Retzius. After birth, most of these cells degenerate and reelin
expression persists in postnatal and adult brain. The phenotype of neurons that bind secreted reelin and whether the
continuous secretion of reelin is required for physiological functions at postnatal stages remain unknown.
Methodology/Principal Findings: Combining immunocytochemical and pharmacological approaches, we first report that
two distinct patterns of reelin expression are present in cultured hippocampal neurons. We show that in hippocampal
cultures, reelin is secreted by GABAergic neurons displaying an intense reelin immunoreactivity (IR). We demonstrate that
secreted reelin binds to receptors of the lipoprotein family on neurons with a punctate reelin IR. Secondly, using calcium
imaging techniques, we examined the physiological consequences of reelin secretion blockade. Blocking protein secretion
rapidly and reversibly changes the subunit composition of N-methyl-D-aspartate glutamate receptors (NMDARs) to a
predominance of NR2B-containing NMDARs. Addition of recombinant or endogenously secreted reelin rescues the effects
of protein secretion blockade and reverts the fraction of NR2B-containing NMDARs to control levels. Therefore, the
continuous secretion of reelin is necessary to control the subunit composition of NMDARs in hippocampal neurons.
Conclusions/Significance: Our data show that the heterogeneity of reelin immunoreactivity correlates with distinct
functional populations: neurons synthesizing and secreting reelin and/or neurons binding reelin. Furthermore, we show that
continuous reelin secretion is a strict requirement to maintain the composition of NMDARs. We propose that reelin is a
trans-neuronal messenger secreted by GABAergic neurons that regulates NMDARs homeostasis in postnatal hippocampus.
Defects in reelin secretion could play a major role in the development of neuropsychiatric disorders, particularly those
associated with deregulation of NMDARs such as schizophrenia.
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Introduction
Reelin is a large secreted protein of the extracellular matrix [1]
and a signaling molecule whose best characterized pathway
involves two lipoprotein receptors, apolipoprotein E receptors 2
(ApoER2) and very-low-density lipoprotein receptor (VLDLR)
[2,3]. In addition to ApoER2/VLDLR, reelin binds the cell
adhesion molecule of the integrin family, a3b1 [4]. Understanding
the roles of reelin, is one important key to deciphering the
functions of the extracellular matrix, a molecular ensemble that
forms an intricate mesh around neurons.
In the central nervous system, the spatiotemporal expression of
reelin varies markedly from the prenatal to adult stage. Although
the vast majority of Cajal-Retzius cells which express reelin during
embryonic development [5,6] die after the first postnatal week [7],
reelin expression persists in postnatal and adult rodent brain
[5,8,9]. At these later stages, reelin protein and mRNA localize to
a subset of GABAergic neurons in the hippocampus [5,9,10].
Reelin secretion is independent of Ca
2+, ionotropic glutamate
receptors activity [11] and of neuronal activity [12]. Despite the
proposed constitutive mode of reelin secretion [11], the charac-
terization of neurons secreting and/or binding reelin in the
postnatal brain remains to be definitively addressed. Moreover, the
physiological outcome of the continuous secretion of reelin in the
postnatal brain is unknown.
Reelin serves different functions during brain development and
adulthood. During embryonic development, reelin is crucial to the
correct cytoarchitecture of laminated structures [13,14]. At
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[15,16] and dendritic growth [17]. We have recently shown that
reelin governs the maturation and surface mobility of glutamate
receptors of the N-methyl D-aspartate (NMDA) subtype in the
hippocampus [12,18]. Thus, understanding the functional signif-
icance of the complex expression pattern of reelin in postnatal
neurons will aid in unraveling the roles of this extracellular matrix
protein in the adult brain.
Here, we demonstrate that in hippocampal cultures, reelin is
synthesized and secreted by GABAergic neurons. We show that
continuous reelin secretion is necessary to maintain the subunit
composition of NMDARs. These data are consistent with the
hypothesis that reelin is a transneuronal messenger that regulates
glutamate receptor homeostasis in post-natal hippocampal neu-
rons.
Results
Different types of reelin immunoreactivity coexist in the
hippocampus in vitro
We analyzed, during maturation, the patterns of reelin
expression in cultured hippocampal neurons with the G10
antibody [9,18]. Two types of immunoreactivities and expression
profiles were consistently observed in neuronal somata between 6
and 21 days in vitro (div, Figure 1). The distribution of staining
intensities discriminated two distinct groups of neurons (Figure 1A).
One population was characterized by its diffuse and intense
perinuclear immunoreactivity (IR) and was referred to as neurons
with ‘‘intense reelin IR’’ (Figure 1B, C). In contrast, the second
population displayed a punctate and less intense labelling that was
named ‘‘punctate reelin IR’’ (Figure 1B, D). Regardless of intense
Figure 1. Profile of intense and punctate reelin IR during hippocampal maturation. (A) Bins of average fluorescent intensities detected in
somata of 12 div hippocampal neurons immunostained for reelin (n=380 neurons). Intensities ranging from 100 to 4030 were divided into 110 bins
and the number of somata was counted within each bin. The vertical lines mark the threshold values used to identify the different reelin-positive
populations (1450 and 2650). (B) Top: Representative image of somatic reelin immunoreactivities found in 12 div hippocampal neurons. Bottom:
reelin immunofluorescence (red) overlaid with MAP2 counterstain (green). Neurons with intense and punctate reelin IR are present in the same field
as neurons with no detectable reelin IR. (C, D) Expression profiles between 6 and 21 div, of intense (C,P ,0.001: ***versus 6 and 8 div, DD versus
21 div) and punctate reelin IR (D,P ,0.01: **versus 6 div, D versus 8 div). Bar graphs represent the average percentage6sem of reelin-positive
neurons within the total number of neuronal somata counted on the corresponding phase-contrast images. High magnification images of 12 div
neurons displaying intense (C) or punctate reelin IR (D) are shown on the top. Images were taken from the same coverslip with identical exposure
times.
doi:10.1371/journal.pone.0005505.g001
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extending into neurites (Figure 1C, D).
The expression profiles of these two types of IR varied similarly
between 6 and 14 div (Figure 1C, D). The proportion of neurons
with intense reelin IR significantly increased between 8 and 9 div
(8.960.5%, n=10 versus 17.561.2%, n=11) and stabilized
between 9 and 14 div (22.161.2%, n=17, F(4,44)=16.7,
P,0.001; Figure 1C; [18]). The expression profile of the
population with punctate reelin IR followed the same pattern
between 6 and 14 div (9.260.8%, n=9 versus 21.461.7%,
n=17; Figure 1D). At 21 div, the percentage of neurons with
punctate reelin IR remained stable with regard to 9–14 div
(22.261.7%, n=17) whereas it decreased for intense reelin IR
(15.161.2%, n=17; Figure 1C, D). Thus, two distinct types of
reelin immunostaining are present throughout hippocampal
maturation.
Although, these two types of labelling have been reported in
vivo in different brain areas including the hippocampus of adult
rodents [9], their physiological roles remain unknown. We next
examined the physiological role of reelin-expressing neurons at the
peak of reelin expression between 9 and 15 div.
Neurons secreting reelin are GABAergic
To discriminate between the intracellular and secreted form of
reelin, protein secretion was blocked with brefeldin A (BFA), an
inhibitor of protein translocation from the endoplasmic reticulum
to the Golgi apparatus [19]. BFA dramatically altered the
distribution of reelin staining intensities (Figure 2A) but not the
density of reelin immunoreactivity (Figure S1A) and specifically
abolished the detection of punctate reelin IR (Figure 2A, C). The
time course of action of BFA shows that the fraction of punctate
reelin IR neurons after 9 and 16 hours of BFA treatment was
decreased to 4.562.1% and 4.360.5% (n=5 and 6), values
significantly different from 18.061.4% before treatment (n=8;
F(2,16)=33.05, P,0.001). The BFA-dependent blockade was fully
reversible following drug washout: the fraction of neurons with
punctate reelin IR following BFA recovery was not different from
the value obtained prior treatment (21.561.4%, n=6 versus
Figure 2. Reelin is secreted by GABAergic neurons. (A, B) Distribution of average intensities measured on neuronal somata immunolabelled
for reelin after 9 and 16 hours of BFA treatment (n=231 neurons, A) and after wash-out of BFA (n=282 neurons, B). The intensity distribution was
altered after BFA treatment (A), and the loss of the low intensity group was reverted following BFA washout (recovery, B). (C) Time course of the
effect of BFA treatment on reelin IR populations. Treatment with BFA did not change the proportion of intense reelin IR neurons: 21.161.2% before
treatment (n=8) and 21.061.9% after 16 hours (n=6), whereas it caused a significant decrease in the fraction of punctate reelin IR neurons. Note the
recovery of the fraction of punctate reelin IR neurons after BFA wash-out. Values are mean percentage6sem of the total number of neuronal somata.
***P,0.001. (D) Top: Representative images of intense reelin IR (red) with GAD67 (green, left) or GAD65 (green, right). Bottom: Average
percentage6sem of intense reelin IR neurons colabelled with either GAD67 or GAD65 after BFA or vehicle treatment. Values were 100.060.0% and
91.164.5% (n=3 and 3) in BFA-treated conditions, 97.261.3% and 93.665.2% (n=4 and 5) in vehicle conditions.
doi:10.1371/journal.pone.0005505.g002
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either population (Figure S1B). To confirm that reelin secretion
was blocked by BFA, the levels of secreted reelin were measured in
the culture medium by western blot, at different times following
BFA treatment (Figure S2 and Text S1). The content of secreted
reelin was dramatically decreased after 3 and 9 hours of BFA
treatment compared to vehicle (Figure S2B, C). Altogether, these
results show that secretion blockade selectively abolished punctate
reelin IR without altering the intense reelin IR population. These
data suggest that intense reelin IR neurons specifically secrete
reelin.
We next examined whether neurons secreting reelin were
associated with a selective neuronal subtype. Double labeling of
reelin with GAD67 or GAD65, two different isoforms of glutamate
decarboxylase, showed that virtually all intense reelin IR were
GAD67- or GAD65-positive (Figure 2D and Table 1). To
determine whether intense reelin IR could be present in excitatory
neurons, we performed double immunostaining of reelin with the
vesicular glutamate transporters, VGlut1 or VGlut2. The
immunoreactivity for VGlut1 and VGlut2 was predominantly
distributed along neurites. Therefore, in most cases determining
whether VGlut1- or VGlut2-positive neurites belong to intense
reelin IR somata was very ambiguous. However, the few intense
reelin IR somata from which neurites could be tracked with
sufficient confidence (n=12) were mostly VGlut negative (n=9). A
small population (n=3) displayed a faint VGlut staining that was
just above background threshold. To further prove that neurons
secreting reelin are exclusively GABAergic, dual labeling of reelin
with GAD67 or GAD65 was performed in conditions in which
only intense reelin IR neurons are present. To obtain a
homogeneous population of intense reelin IR neurons, we treated
cultures with BFA. In these conditions, neurons with intense reelin
IR were strictly co-labelled with either GAD67 or GAD65
(Figure 2D). Altogether, these data show that intense reelin IR is
associated to GABAergic neurons and indicate that reelin is
secreted by GABAergic neurons in postnatal hippocampus. In
accord with our observations, reelin expression has previously
been reported to colocalize with GABAergic markers in the
hippocampus of adult rodents [5,9,10].
Reelin immunoreactivity segregates two distinct
functional populations
To determine whether intense reelin IR neurons synthesize
reelin, we studied the time course of action of cycloheximide, an
inhibitor of protein synthesis [20]. Inhibition of protein synthesis
progressively abolished intense reelin IR without affecting the
punctate reelin IR (Figure 3A, B and Figure S3A). Intense reelin
IR was significantly decreased within 3 hours of treatment
(8.461.7%, n=3) compared to untreated (23.661.7%, n=4) or
1 hour (15.363.3%, n=3; F(2,7)=12.0, P,0.01) and was
abolished after 9 and 16 hours (3.161.6% and 1.861.0%, n=3
and 3, P,0.001). The vehicle had no effect on either reelin-
positive populations (Figure 3A inset and Figure S3B, C). We
concluded that the intense reelin IR pattern is associated with
synthesis functions.
Since neurons with punctate reelin IR are BFA-sensitive, we
next challenged the hypothesis that the punctate reelin IR was
associated with receptor-bound reelin. Secreted reelin binds
ApoER2 and VLDLR which are widely expressed by hippocam-
pal neurons in culture [18]. BFA is a broad spectrum inhibitor of
secretion and a potential pitfall stemming from BFA experiments
(Figure 2) is that blocking secretion could have reduced the
number of neurons expressing ApoER2 and/or VLDLR thereby
causing a decrease in punctate reelin IR. This possibility was ruled
out because BFA treatment did not affect either ApoER2 or
VLDLR labeling (ApoER2-positive neurons: untreated
68.962.1%, vehicle 68.162.1%, BFA 69.164.4%, n=3;
VLDLR-positive neurons: untreated 24.761.8%, vehicle
24.961.6%, BFA 30.568.4%, n=3). To examine whether the
punctate reelin labeling was due to reelin bound to receptors,
hippocampal neurons were treated with the Receptor Associated
Protein fused with GST (GST-RAP). RAP is a molecular
chaperone for the low-density lipoprotein receptor family and is
widely used as a functional lipoprotein antagonist [21]. It prevents
the binding of reelin to lipoprotein receptors [22], in turn
disrupting the physiological functions of reelin [12,17,18,23].
GST-RAP selectively abolished punctate reelin IR in a dose
dependent manner but had no effect on the intense reelin IR
population (Figure 3C, D). The control GST was devoid of effect
on both types of reelin-immunoreactive neurons (Figure 3C inset).
Thus, preventing the binding of reelin to its lipoprotein receptors
mimicked the effect of secretion blockade. In contrast, blocking
reelin receptors of the integrin family did not affect reelin IR
(Table S1) [24]. These results demonstrate that the punctate reelin
IR population is formed by neurons that bind secreted reelin onto
lipoprotein receptors.
Altogether, these data show that intense and punctate reelin IR
discriminate two distinct neuronal populations: reelin is synthe-
sized and secreted by intense reelin IR neurons that are
GABAergic, whereas punctate reelin IR neurons are characterized
by the presence of receptor-bound reelin.
Characterization of punctate reelin IR neurons
To examine the neuronal subtype associated to the punctate
reelin IR population, we performed colabellings of reelin with
GAD65 (Table 2) or VLDLR (Figure S4). First, in contrast to the
intense reelin IR population, the fraction of punctate reelin IR
neurons expressing GAD65 represented an average of 54%
between 6 and 21 div (Table 2). In addition, following 9 hours
treatment with cycloheximide, a condition in which all reelin-
positive neurons are punctate, a similar distribution was observed
(i.e. 50.265.1% of punctate reelin IR neurons were GAD65
immunoreactive, n=3). Thus, punctate reelin IR neurons are
equally distributed between GABAergic and non-GABAergic
populations. Second, dual labeling of reelin with VLDLR showed
that virtually all punctate reelin IR neurons co-express VLDLR
(100.060.0%, n=3; Figure S4). These data suggest that regardless
of their GABAergic or non GABAergic phenotype, punctate reelin
IR neurons which result from receptor-bound reelin, express the
reelin receptor VLDLR.
Table 1. Hippocampal neurons displaying intense reelin IR
are GABAergic.
div
Intense reelin IR neurons (%)
coexpressing n
GAD 67 GAD 65 GAD 67 GAD 65
6 93.963.2 96.363.7 3 3
8 97.262.8 97.262.8 3 4
9 98.661.4 96.861.9 4 4
14 95.162.8 93.665.2 9 5
21 96.062.2 74.6612.3 10 3
Average percentage6sem of intense reelin IR neurons colabelled either with
GAD67 or GAD65 during in vitro maturation in untreated conditions.
doi:10.1371/journal.pone.0005505.t001
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composition of functional NMDARs
We nextsearched for the physiological function of the continuous
secretion of reelin by a subpopulation of hippocampal GABAergic
neurons. NMDA receptors (NMDARs), a subclass of the ionotropic
excitatory L-glutamate receptors, are heteromeric channels of
obligatory NR1 subunits in combination with either NR2 (NR2A-
NR2D) or NR3 subunits [25]. In the mammalian forebrain,
NMDAR assembly is regulated during development from predom-
inance of NR2B-containing to NR2A-containing NMDARs
[18,24,26–28]. This process is governed by activity, experience
[24,29–31] and also by the extracellular environment, including cell
adhesion molecules and the extracellular matrix protein reelin
[12,18,24]. Here, we examined the functional consequences of
reelin secretion blockade on the subunit composition of NMDARs.
Figure 3. Intense reelin IR neurons synthesize reelin whereas punctate reelin IR neurons are characterized by the presence of
receptor-bound reelin. (A) Distribution of average intensities of reelin IR measured on somata of neurons treated with cycloheximide (n=270
neurons) or vehicle (inset, n=240 neurons) for 9 and 16 hours. Cycloheximide altered the distribution of average intensities corresponding to intense
reelin IR whereas it had no effect on the distribution of lower intensities. Inset: the vehicle did not affect the distribution of reelin IR intensities. (B)
Time course of the effect of cycloheximide on the proportion of intense and punctate reelin IR. Cycloheximide had no effect on the punctate reelin IR
population whereas it progressively decreased the fraction of intense reelin IR neurons. ***P,0.001. (C) Distribution of average intensities of reelin
immunofluorescence measured on neuronal somata after treatment with 40 or 50 mg/ml of GST-RAP (n=393 neurons) or GST alone at the same
concentration (inset, n=382 neurons). Treatment with GST-RAP altered the distribution of low intensities whereas GST had no effect. (D) Dose
dependent effect of GST-RAP on the punctate reelin IR population. GST-RAP was used at 25, 40 and 50 mg/ml. A significant decrease of punctate
reelin IR was observed with 40 and 50 mg/ml of GST-RAP (4.561.5% and 3.160.7%; n=3 and 3) whereas no effect was detected with a concentration
of 25 mg/ml compared to untreated (22.261.4% and 21.362.2%; n=3 and 3; F(3,8)=45.7, ***P,0.001). Increasing concentrations of GST-RAP had no
effect on the fraction of intense reelin IR neurons. Values are mean percentage6sem of the total number of neuronal somata.
doi:10.1371/journal.pone.0005505.g003
Table 2. Fraction of punctate reelin IR hippocampal neurons
expressing GAD65.
div
Punctate reelin IR neurons
expressing GAD65 (%) n
6 41.768.3 3
8 52.0614.9 4
9 56.269.5 4
14 59.164.6 5
21 61.7615.5 3
Average percentage6sem of punctate reelin IR neurons colabelled with GAD65
during in vitro maturation in untreated conditions.
doi:10.1371/journal.pone.0005505.t002
Reelin Secretion and NMDARs
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(Ca
2+). NMDARs activation was monitored by the increase of
intracellular Ca
2+ concentration upon NMDA application using
the fluorescent Ca
2+ indicator, Oregon Green BAPTA1-AM. The
sensitivity of NMDA-stimulated Ca
2+ influx to the antagonist
ifenprodil was used to quantify the fraction of NR2B-containing
NMDARs (Figure 4). Ifenprodil at 3 mM, provides a maximal and
selective block of NR1/NR2B diheteromeric receptors [32]. As
expected from the developmental loss of NR2B subunits
[18,30,33,34], the sensitivity of the NMDA-stimulated Ca
2+ influx
to ifenprodil was substantially greater in 6 div neurons compared
to 10 div neurons (Figure 4A). The effect of ifenprodil was not the
result of dye bleaching since two sequential NMDA stimulations
induced identical Ca
2+ elevations (Figure S5).
We examined whether blocking secretion with BFA affected the
subunit composition of 10 div-NMDARs. In 10 div neurons
treated with BFA for 15 hours, the NMDA-evoked Ca
2+ responses
were much more sensitive to the NR2B antagonist compared to
vehicle-treated or untreated neurons (Figure 4B). Remarkably, the
effect of BFA was fully reversible within 24 hours of BFA wash-out
(Figure 4B). Altogether, these data show that secretion blockade
increased the fraction of functional NR2B-containing NMDARs.
We next examined whether continuous reelin secretion is
necessary to maintain lower fractions of functional NR2B-
containing NMDARs.
Reelin secretion is necessary to maintain the subunit
composition of NMDARs
Brefeldin A is a non-selective inhibitor of protein secretion. To
demonstrate that the lack of reelin secretion caused the increase in
the fraction of NR2B-containing NMDARs, we performed rescue
experiments. We examined whether endogenously secreted reelin
or exogenous recombinant reelin was sufficient to rescue the BFA-
dependent effects. Neurons were treated with BFA alone during
9 hours; then incubated, in the continuous presence of BFA, with
reelin for the following 13 hours. Endogenous reelin secreted by
hippocampal neurons was present in conditioned medium
collected from 16–17 div cultures (BFA+CM, see materials and
methods), and exogenous recombinant reelin was added at a
concentration of 2.50–5.55 nM (BFA+rRln; [18]). In these
conditions, the NMDA-evoked Ca
2+ responses were much less
sensitive to ifenprodil compared to their respective control
(73.864.2% in BFA+CM versus 45.568.0% in BFA+M;
78.0611.5% in BFA+rRln versus 35.268.5 in BFA+mock,
Figure 4C). These data demonstrate that soluble reelin is necessary
and sufficient to rescue the effects of secretion blockade and to
regulate NMDARs homeostasis.
Discussion
Our study provides new insights into the interactions between
extracellular matrix proteins and glutamate receptors. First, we
demonstrate that two distinct neuronal populations of expressing
reelin IR coexist in the hippocampus in vitro to serve different
functions. A subpopulation of purely GABAergic neurons
synthesize and secrete reelin which in turn binds the lipoprotein
receptors of another neuronal subpopulation. Second, we
discovered that continuous reelin secretion is a strict requirement
to maintain the composition of NMDARs.
The two types of somatic reelin IR we described here have been
reported in different brain areas of adult primates [35]. Whether
they also correlate with distinct physiological functions in the
primate brain is unknown. During embryonic development, reelin
is secreted by Cajal-Retzius neurons [1,13]. Recent evidences
indicate that Cajal-Retzius neurons are glutamatergic [36,37].
Together with our results, these data suggest that the multiple and
different functions of reelin during development and adulthood are
linked to diverse reelin producing cell types. Further studies will be
necessary to determine whether GABAergic neurons also produce
reelin in other postnatal structures.
We used different approaches to deplete the availability of
reelin. We either blocked the secretion with BFA or the protein
synthesis with cycloheximide. BFA treatment selectively abolished
the fraction of punctate reelin IR whereas cycloheximide
selectively decreased the intense reelin IR population. These data
show that the intense reelin IR pattern is associated with synthesis
and secreting functions. This interpretation is consistent with the
observation that intense reelin IR neurons were not detected in
non-permeabilized conditions suggesting that intense reelin IR is
intracellular (not shown). One might expect treatment with
cycloheximide to diminish the punctate reelin IR population by
limiting the pool of synthesized reelin available for binding.
Several explanations can account for the lack of effect within the
time scale of the experiment; the turnover rate of unbound reelin
could be very slow or alternatively, the pool of secretable reelin
may not be sufficiently depleted and and thus still be readily
releasable even after synthesis have been blocked for a long period
of time. Finally, our observation is compatible with reelin recycling
in punctate reelin IR neurons since it is known that after binding
to lipoprotein receptors, reelin undergoes endocytosis [2,38]. BFA
can inhibit recycling whereas cycloheximide should not affect this
mechanism, consistent with our observation that BFA but not
cycloheximide decreased the fraction of punctate reelin IR
neurons.
The present data and our previous work [18], show that
ApoER2 is expressed in most hippocampal neurons and that
VLDLR-positive neurons represent a much smaller population
(25%). As a consequence, a large fraction of hippocampal neurons
would be expected to display a punctate IR pattern. In contrast, at
the plateau of reelin expression, the neuronal population
associated to receptor-bound reelin represented a small percentage
of hippocampal neurons (22%). This could be due to the presence
of neurons that do not reach the detection threshold for
immunocytochemistry or that levels of unbound reelin in the
culture medium is not high enough to bind all receptors.
Strickingly, the fractions of punctate reelin IR neurons and
VLDLR-positive neurons are very similar, and reelin could
preferentially bind to neurons expressing VLDLR or both
VLDLR and ApoER2. In support of this hypothesis, we observed
that all punctate reelin IR neurons express VLDLR.
Several studies have shown that, in the postnatal and adult
brain, reelin modulates neuronal plasticity, including long-term
potentiation, dendritic branching, maturation and surface diffu-
sion of NMDARs [12,15–18]. However, whether the continuous
secretion of reelin is required for its physiological function at
postnatal stages was never addressed. So far, BFA is the only
inhibitor known to block reelin secretion [11], thus we treated
hippocampal cultures with BFA to assay the physiological
consequences of the lack of reelin secretion. Blockade of the
secretory pathway perturbed the homeostasis of NMDARs and
changed the NR2B-/NR2A-NMDARs ratio. BFA could either
block the basal insertion of NR2A-NMDARs or increase the
number of functional NR2B-NMDARs, therefore enhancing in
both cases the fraction of ifenprodil sensitive-NMDARs. Note-
worthy, this effect was reversed following the addition of
endogenous or recombinant reelin showing that the continuous
secretion of reelin is necessary to maintain the subunit composition
of NMDA receptors.
Reelin Secretion and NMDARs
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reelin secretion. First, the activation of the reelin signaling
pathway could result in the phosphorylation of NMDARs thus
upregulating NR2B-dependent responses [23]. The fact that a
long incubation period with endogenous or recombinant reelin is
needed to rescue secretion blockade does not favor this hypothesis.
Second, we have previously shown that reelin controls the surface
mobility of both synaptic and extrasynaptic NR2B-containing
NMDARs [12]. We reported that the lack of reelin, selectively
affected the surface mobility of NR2B- versus NR2A-containing
NMDARs. Reelin depletion significantly decreased the surface
mobility of extrasynaptic NR2B-containing NMDARs [12]. The
effect of increasing the availability of NR2B-containing NMDARs
could in turn contribute to the enhancement the fraction of
functional NR2B-containing receptors. Finally, the fact that reelin
is a protein of the extracellular matrix suggests that its site of action
may be located in perineuronal nets. Blockade of the secretory
pathway perturbed the homeostasis of NMDARs and selectively
abolished one type of reelin IR. These data not only suggest that
diffusion of reelin is crucial for its physiological action, but also
favor the hypothesis that reelin diffuses broadly into the interstitial
space to act as a trans-neuronal messenger. This does not rule out
a possible autocrine function for reelin through cell surface
diffusion and/or vesicular transport.
Based on our data, we propose that defects in reelin secretion
could play a major role in the development of neuropsychiatric
disorders. Particularly those associated with deregulation of
NMDARs homeostasis and lower expression levels of reelin, such
as schizophrenia [39,40].
Materials and Methods
Hippocampal cultures
Hippocampi were dissected from postnatal day 0 Swiss mice
brains. First, tissues were enzymatically dissociated for 40 min at
37uC in HBSS containing papain (20 units/ml, Sigma-Aldrich).
Papain was then inactivated with Trypsin Inhibitor (125 mM,
Sigma-Aldrich) in the presence of bovine serum albumin (0.25%,
Sigma-Aldrich). Hippocampi were then mechanically triturated in
the culture medium. Finally, dissociated cells were plated on poly-
L-lysine coated round coverslips (10 mg/ml, Sigma-Aldrich) at a
density of 462 per mm
2. Neurons were grown in Minimum
Essential Medium (MEM, GIBCO Invitrogen) supplemented with
5% of Serum Supreme (Biowhittaker), 28.3 mM D-glucose and
0.1% of Mito+ Serum Extender (Becton Dickinson). Media were
fully renewed the day after plating and exchanged weekly.
Cultures were kept in a humidified atmosphere of 5%CO2-
95%O2 at 36.5uC. To avoid glial cell multiplication, cultures were
treated at 9 day in vitro (div) with 0.2 mg/ml 59-fluoro-2-
deoxyuridine and 0.5 mg/ml uridine (FUDR, Sigma-Aldrich).
Animals
All experiments were conducted in strict compliance with
European directives and French laws on animal experimentation
(authorization number 3307016).
Treatment of cultures
Brefeldin A (BFA, Sigma-Aldrich) was used as previously
described (0.75 mg/ml) [41]. Absolute ethanol was used as a control
and added to the same final volume percentage. For immunocyto-
chemistry, BFA treatments were performed between 12 and 14 div.
After 9 h, coverslips were washed 3 times with serum-free culture
medium and returned to the incubator during 10 hours for recovery
beforefixation.Forcalciumimaging,neuronsweretreatedwithBFA
for 15 h and imaged at 9, 10 and 15 div. For recovery experiments,
BFA was washed after 9 to 15 h incubation and neurons were
imaged 24 h to 28 h later at 11 and 15 div. Rescue experiments
were performed after a 9 h treatment with BFA, by adding
conditioned medium collected from 16–17 div cultures or recom-
binant reelin, in the presence of BFA for the following 13 hours.
Neurons were then recorded at 9, 10 and 11 div. Recombinant
reelin and the mock control were produced as described previously
[12]. The presence of reelin in conditioned medium and in the
recombinant fraction were assessed by western blot.
Cultures were treated at 9 div for 24 hours with different
concentrations - 25, 40 and 50 mg/ml - of either the Receptor-
Associated Protein fused with glutathione S-transferase (GST-
RAP) or the control GST [18].
Cycloheximide (Sigma-Aldrich) treatments were performed at
13 div. Cycloheximide was added directly to the culture medium
at a final concentration of 10 mM. Absolute ethanol with the same
final volume percentage was used as a control.
Immunocytochemistry
Hippocampal cultures were fixed in 4% paraformaldehyde-
containing Phosphate Buffer Solution (PBS), pH 7.4 for 40 min at
room temperature. Quenching was performed with 0.1 M glycine
(Sigma-Aldrich) in PBS for 45 min. Permeabilization was achieved
with PBS containing 0.1% triton X-100 (Sigma-Aldrich) for 5 min
or PBS containing 0.05% saponin for 30 min. Non specific
binding was blocked with 2 sequential incubations of 15 min
duration with blocking buffer. Blocking buffer consisted of PBS
containing either 10% donkey serum (Chemicon) or 0.2% Bovin
Serum Albumin (Sigma-Aldrich) plus 0.05% saponin. Bovin
Serum Albumin was used at 1% with anti-ApoER2 and anti-
Figure 4. The increase of NR2B-mediated NMDARs Ca
2+ responses induced by BFA is rescued by reelin. (A) Examples of Ca
2+ responses
recorded in a 6 div (top) or 10 div neuron (bottom). At 6 div, the NMDA-induced Ca
2+ influx in the presence of ifenprodil (3 mM) was largely reduced
compared to the response evoked by NMDA alone (100 mM). Inset: pseudocolor scale with images of Ca
2+ responses taken at the time points
indicated below. At 10 div the effect of ifenprodil on the NMDA-evoked response was less prominent. Bar graph representing average percentage of
NMDA-induced Ca
2+ influx remaining after ifenprodil application during maturation. Values were 57.0610.0% at 6 div, 56.566.8% at 7 div, and
59.066.6% of control response at 8 div. They were significantly different between 9 and 15 div: 86.664.2% at 9 div, 80.267.2% at 10 div, 83.363.4%
at 12 div and 95.364.7% at 15 div (F(6,130)=17.2, ***P,0.001). (B) Examples of NMDA-stimulated Ca
2+ responses recorded in neurons either treated
with vehicle or BFA for 15 hours or after recovery from BFA blockade. In BFA-treated conditions, the NMDA-induced Ca
2+ influx in the presence of
ifenprodil (3 mM) was largely decreased compared to the response evoked by NMDA alone (100 mM). After recovery, the effect of ifenprodil was
dramatically reduced compared to BFA-treated conditions. Bar graph summarizing the average percentage of NMDA-evoked Ca
2+ responses
remaining after ifenprodil application in the conditions described above (vehicle: 86.063.3%, BFA: 51.066.5% and recovery: 93.466.1% of control
response, F(2,87)=40.8, ***P,0.001). (C) Examples of NMDA-stimulated Ca
2+ responses recorded after incubation of BFA-treated neurons with rRln
(BFA+rRln) or the control mock (BFA+mock). In the presence of BFA+rRln, the effect of ifenprodil was largely reduced compared to BFA+mock
conditions. Bar graph summarizing rescue experiments using conditioned medium (BFA+CM) or recombinant reelin (rRln). Respective controls for
conditioned medium and rRln were medium not exposed to cultured neurons (M) or mock (mock). Experiments were performed at 9, 10 and 15 div.
**P,0.01. The number of neurons recorded in each condition is indicated.
doi:10.1371/journal.pone.0005505.g004
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4uC in a humidified atmosphere with the primary antibodies
diluted in blocking buffer. Preparations were then washed twice
15 min followed by a 30 min rinse in blocking buffer and
incubated with the secondary antibodies for 80 min at room
temperature in a humidified atmosphere. Cells were then rinsed
extensively with the blocking buffer and mounted on glass
coverslips in Aqua-PolyMount (PolySciences).
Reelin was detected with the monoclonal antibody G10 (1:2000,
Chemicon) and visualized with a cyanine 3 (Cy3)-conjugated anti-
mouse IgG (1:500, Chemicon) or an Alexa Fluor 568-conjugated
anti-mouse IgG (1:500, Molecular Probes). MAP2 was revealed
with a rabbit polyclonal antibody (1:500) and visualized with Alexa
Fluor 647-conjugated anti-rabbit IgG (1:500, Molecular Probes).
To visualize GABAergic neurons, we used antibodies directed
against different isoforms of the GABA synthesizing enzymes, the
rabbit anti-Glutamic Acid Decarboxylase 67 (GAD67, 1:1000,
Chemicon) and the rabbit anti-GAD65 (1:1000, Chemicon).
These primary antibodies were revealed with cyanine 5 (Cy5)-
conjugated anti-rabbit IgG (1:500, Jackson Immunoresearch) or
Alexa Fluor 488-conjugated anti-rabbit IgG (1:500, Molecular
Probes). The vesicular glutamate transporters 1 and 2 were
detected with rabbit anti-VGlut1 (1:1000) or VGlut2 (1:2500)
respectively and revealed with Cy5-conjugated anti-rabbit IgG
(1:500, Jackson Immunoresearch). Reelin lipoprotein receptors
were labeled with the rabbit anti-ApoER2 (1:200, Santa Cruz
Biotechnology) and the mouse anti-VLDLR (1:500, Santa Cruz
Biotechnology) antibodies revealed with Alexa Fluor 488 anti-
rabbit IgG (1:500, Molecular Probes) and Cy3-conjugated anti-
mouse IgG (1:500, Jackson Immunoresearch) respectively.
Image analysis of immunostaining
Slides were viewed with a 406oil objective on an Axiophot II
microscope (Zeiss, France). Image acquisition was done with a
Quantix digital cooled CCD camera (Photometrix, Tucson, AZ)
driven by IPLab software (Scanalytics, Fairfax, VA, USA). The
exposure settings were kept identical for each condition. For each
fluorescent image that was acquired, the corresponding phase-
contrast field was collected. The 12 bit images were analysed with
MetaMorph software 7.1.2.0 (Universal Imaging, Evry, France) as
follows. Somata were demarcated on the phase-contrast image,
and the regions of interest (ROIs) were transferred automatically
on the corresponding fluorescent images. Positive ROIs were
selected using intensity thresholds determined by the distribution
of intensities obtained amongst different experiments. Positive
somata were then counted over all of the images acquired on
coverslips from one experiment and normalized to the total
number of neurons detected on the corresponding phase-contrast
images.
Calcium imaging and analysis
Hippocampal neurons were loaded with 2 mM Oregon Green
488 BAPTA-1 AM (Molecular Probes) for 30 min at 37uCi n
culture medium. Coverslips were then washed 4 times with the
Mg
2+-free recording medium containing (in mM): NaCl (160),
KCl (2.4), Hepes (10), glucose (10), glycine (0.02) and CaCl2 (3),
pH=7.3 and Osm=325 mOsm/l. Coverslips were then mounted
onto a custom made recording/perfusion chamber positioned on
the movable stage of an inverted microscope Olympus IX-71.
Cells were superfused (0.7 ml/min) with the recording medium.
Signals were detected using a CCD camera (Quantem 512SC) and
acquired with the Metamorph software 7.1.2.0 (Universal Imaging
Corp). Images were acquired with the filter set 41001, HQ 480/40
(Chroma Technology, Brattelboro, VT, USA) for excitation and
HQ 535/50 (Chroma Technology) for emission. Recording
sessions were between 40 and 45 minutes. The acquisition rate
was 0,017 Hz during baseline (10–12 min) and ifenprodil
application (3 mM; 3 min) and 0.5 Hz during NMDA (100 mM)
and NMDA (100 mM)+ifenprodil (3 mM) applications. Phase
contrast images were acquired prior and after each experiment
to control for cellular integrity.
Data were analysed using the Metamorph software 7.1.2.0.
After background correction, positive ROIs were demarcated only
on somata whose integrity was confirmed in phase contrast
images. Raw values (Ft) were normalized to the average of baseline
calculated before NMDA application (Fr) and data were plotted as
DF/F=(Ft2Fr)/Fr. NMDA responses were calculated as DF/F
(NMDA6ifen)2DF/F (before NMDA6ifen).
Statistical analysis
All experiments were performed at least in 3 different cultures, n
is the number of cultures used for each condition unless stated
otherwise. All data are expressed as the mean6SEM. Statistical
analysis were performed by ANOVA followed by Tukey’s multiple
comparison test where significant (P,0.05, Kyplot 2.0b1.3).
Supporting Information
Figure S1 Time course of reelin immunostaining during
treatment with BFA or vehicle. (A) Representative images of
intense and punctate reelin IR after 3 hours and 16 hours of BFA
treatment and after BFA recovery. (B) Treatment with vehicle does
not affect the percentage of reelin immunoreactive neurons at
various time points. Values for intense reelin IR were: before
treatment (0 hr) 21.161.2%, n=8; 3 hours 19.762.0%, n=3;
6 hours 21.261.0%, n=3; 9 hours 18.861.3%, n=5; 16 hours
21.260.4%, n=6 and recovery 21.362.6%, n=6. Values for
punctate reelin IR were: untreated (0 hr) 18.061.4%, n=8;
3 hours 17.762.5%, n=3; 6 hours 19.061.6%, n=3; 9 hours
18.161.4%, n=5; 16 hours 17.461.1%, n=6 and recovery
17.760.2%, n=6.
Found at: doi:10.1371/journal.pone.0005505.s001 (6.53 MB TIF)
Figure S2 Secretion blockade decreases the levels of total and
full-length reelin present in the medium of cultured hippocampal
neurons. (A) Example western blot of the time course of BFA
treatment on reelin secreted in the medium of 13 div hippocampal
cell cultures. Bands corresponding to full-length reelin (400 kDa)
and proteolytic products (320 and 180 kDa) were disclosed by the
G10 antibody. Reelin was not detected in medium not exposed to
cultured neurons (medium). (B, C) Time course of the effect of
BFA treatment on the levels of secreted reelin measured by
western blot. For each condition, values are expressed as the
percentage6sem of the corresponding vehicle control. **P,0.01,
***P,0.001. (B) Densitometry measurements of total reelin
expressed as the sum of the densities of the 3 forms, full-length
reelin (400 kDa) plus the two reelin fragments (320 and 180 kDa).
A significant decrease is observed after 3 hours (53.862.9% of
vehicle) and 9 hours (41.360.4% of vehicle) of treatment
compared to 1 hour treatment with BFA (93.962.1% of vehicle)
or vehicle (n=3; F(3,8)=7.7, P,0.01). (C) Densitometry mea-
surements of the 400 kDa band, corresponding to full-length
reelin, after treatment with either vehicle, 1 hour BFA
(84.863.0%), 3 hours BFA (42.864.0%) or 9 hours BFA
(22.760.4%; n=3; F(3,8)=99.1, P,0.001).
Found at: doi:10.1371/journal.pone.0005505.s002 (5.90 MB TIF)
Figure S3 Time course of reelin immunostaining during
treatment with cycloheximide or vehicle. (A) Representative
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PLoS ONE | www.plosone.org 9 May 2009 | Volume 4 | Issue 5 | e5505images showing intense and punctate reelin IR after 3, 9 and
16 hours of cycloheximide treatment (CHX). (B) The percentage
of reelin immunoreactive neurons was not changed during
incubation with vehicle at various time points. Values for intense
reelin IR were: before treatment 23.761.7%, n=4; 1 hour
21.761.7%, n=3; 3 hours 19.162.7%, n=3; 6 hours
18.762.9%, n=4; 9 hours 20.263.1%, n=3 and 16 hours
19.261.4%, n=3. (C) Values for punctate reelin IR were: before
treatment 18.460.8%, n=4; 1 hour 18.262.6%, n=3; 3 hours
17.962.4%, n=3; 6 hours 19.763.1%, n=4; 9 hours
17.661.0%, n=3 and 16 hours 17.166.2%, n=3.
Found at: doi:10.1371/journal.pone.0005505.s003 (8.10 MB TIF)
Figure S4 Dual labelling of reelin and VLDLR. Representative
image of a punctate reelin IR neuron (A) showing co-expression of
VLDLR (B) in a 14 div hippocampal culture.
Found at: doi:10.1371/journal.pone.0005505.s004 (1.62 MB TIF)
Figure S5 Subsequent applications of NMDA do not induce
run-down of Ca2+ responses. Example of Ca2+ responses kinetics
recorded in a 10 div neuron during subsequent applications of
NMDA. The intensity of Ca2+ response remained stable during
consecutive NMDA applications. On average the amplitude of the
Ca2+ response obtained during the second application of NMDA
represented 94.563.3% of the response evoked by the first
application of NMDA (n=33 neurons).
Found at: doi:10.1371/journal.pone.0005505.s005 (1.56 MB TIF)
Table S1 Supplementary Table
Found at: doi:10.1371/journal.pone.0005505.s006 (0.03 MB
DOC)
Text S1 Supporting Materials
Found at: doi:10.1371/journal.pone.0005505.s007 (0.04 MB
DOC)
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